These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 18223555
1. Frequent loss of 17p, but no p53 mutations or protein overexpression in benign and malignant pheochromocytomas. Petri BJ, Speel EJ, Korpershoek E, Claessen SM, van Nederveen FH, Giesen V, Dannenberg H, van der Harst E, Dinjens WN, de Krijger RR. Mod Pathol; 2008 Apr; 21(4):407-13. PubMed ID: 18223555 [Abstract] [Full Text] [Related]
2. Absence of TP53 alterations in pheochromocytomas and medullary thyroid carcinomas. Herfarth KK, Wick MR, Marshall HN, Gartner E, Lum S, Moley JF. Genes Chromosomes Cancer; 1997 Sep; 20(1):24-9. PubMed ID: 9290950 [Abstract] [Full Text] [Related]
3. [Distinction between benign and malignant pheochromocytomas]. Liu TH, Chen YJ, Wu SF, Gao J, Jiang WJ, Lu ZH, Guan J, Wei SZ, Luo YF, Cao JL, Wan JW. Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):198-202. PubMed ID: 15256107 [Abstract] [Full Text] [Related]
4. Mutations of the p53 gene in human functional adrenal neoplasms. Lin SR, Lee YJ, Tsai JH. J Clin Endocrinol Metab; 1994 Feb; 78(2):483-91. PubMed ID: 8106638 [Abstract] [Full Text] [Related]
6. Von Hippel-Lindau gene alterations in sporadic benign and malignant pheochromocytomas. Dannenberg H, De Krijger RR, van der Harst E, Abbou M, IJzendoorn Y, Komminoth P, Dinjens WN. Int J Cancer; 2003 Jun 10; 105(2):190-5. PubMed ID: 12673678 [Abstract] [Full Text] [Related]
14. Sporadic and familial pheochromocytomas are associated with loss of at least two discrete intervals on chromosome 1p. Benn DE, Dwight T, Richardson AL, Delbridge L, Bambach CP, Stowasser M, Gordon RD, Marsh DJ, Robinson BG. Cancer Res; 2000 Dec 15; 60(24):7048-51. PubMed ID: 11156410 [Abstract] [Full Text] [Related]
15. Allelic loss of chromosomes 8 and 19 in MENX-associated rat pheochromocytoma. Shyla A, Hölzlwimmer G, Calzada-Wack J, Bink K, Tischenko O, Guilly MN, Chevillard S, Samson E, Graw J, Atkinson MJ, Pellegata NS. Int J Cancer; 2010 May 15; 126(10):2362-72. PubMed ID: 19876893 [Abstract] [Full Text] [Related]
16. Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas. Wagata T, Shibagaki I, Imamura M, Shimada Y, Toguchida J, Yandell DW, Ikenaga M, Tobe T, Ishizaki K. Cancer Res; 1993 Feb 15; 53(4):846-50. PubMed ID: 8094033 [Abstract] [Full Text] [Related]
17. Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas. Khosla S, Patel VM, Hay ID, Schaid DJ, Grant CS, van Heerden JA, Thibodeau SN. J Clin Invest; 1991 May 15; 87(5):1691-9. PubMed ID: 2022740 [Abstract] [Full Text] [Related]
18. Overexpression of ERBB-2 was more frequently detected in malignant than benign pheochromocytomas by multiplex ligation-dependent probe amplification and immunohistochemistry. Yuan W, Wang W, Cui B, Su T, Ge Y, Jiang L, Zhou W, Ning G. Endocr Relat Cancer; 2008 Mar 15; 15(1):343-50. PubMed ID: 18310300 [Abstract] [Full Text] [Related]